全文获取类型
收费全文 | 338篇 |
免费 | 56篇 |
出版年
2023年 | 2篇 |
2022年 | 2篇 |
2021年 | 6篇 |
2020年 | 3篇 |
2019年 | 9篇 |
2018年 | 9篇 |
2017年 | 8篇 |
2016年 | 9篇 |
2015年 | 23篇 |
2014年 | 18篇 |
2013年 | 23篇 |
2012年 | 28篇 |
2011年 | 25篇 |
2010年 | 18篇 |
2009年 | 11篇 |
2008年 | 24篇 |
2007年 | 19篇 |
2006年 | 15篇 |
2005年 | 12篇 |
2004年 | 11篇 |
2003年 | 12篇 |
2002年 | 12篇 |
2001年 | 11篇 |
2000年 | 13篇 |
1999年 | 4篇 |
1998年 | 4篇 |
1997年 | 2篇 |
1996年 | 7篇 |
1995年 | 2篇 |
1994年 | 2篇 |
1992年 | 6篇 |
1991年 | 3篇 |
1990年 | 5篇 |
1989年 | 4篇 |
1988年 | 4篇 |
1987年 | 3篇 |
1986年 | 2篇 |
1985年 | 2篇 |
1984年 | 2篇 |
1982年 | 3篇 |
1981年 | 2篇 |
1980年 | 1篇 |
1979年 | 1篇 |
1978年 | 2篇 |
1977年 | 1篇 |
1974年 | 1篇 |
1973年 | 3篇 |
1972年 | 1篇 |
1971年 | 1篇 |
1969年 | 1篇 |
排序方式: 共有394条查询结果,搜索用时 15 毫秒
151.
Malviya M Kumar YC Asha D Chandra JN Subhash MN Rangappa KS 《Bioorganic & medicinal chemistry》2008,16(15):7095-7101
As part of our continuing effort aimed at the development of selective, efficacious and centrally active M1 muscarinic agonists for the treatment of Alzheimer's presenile dementia, a series of N-arylthioureas substituted 3-morpholino arecoline derivatives 9(a-j) were synthesized by using N-benzyl amino ethanol coupling with alpha-bromo acetyl pyridine followed by reduction and cyclization to develop a new class of M1 receptor agonists. Subsequently the synthesized compounds were subjected to in vitro radioligand M1 receptor affinity studies, IP3 formation studies and also to in vivo pharmacological evaluation of memory and learning in male Wistar rats. Derivatives with chloro (9f) and methoxy (9c) groups on the para position of the benzene ring attached to the nitrogen of thiourea showed several fold high affinity for the M1 receptor (in vitro) among all the synthesized molecules 9(a-j), and also significantly elevated IP3 levels and as well elicited beneficial effects in vivo in memory and learning models in rats (rodent memory evaluation, plus and Y maze studies). 相似文献
152.
Dinakaran M Senthilkumar P Yogeeswari P China A Nagaraja V Sriram D 《Bioorganic & medicinal chemistry》2008,16(6):3408-3418
Various 2-(sub)-3-fluoro/nitro-5,12-dihydro-5-oxobenzothiazolo[3,2-a]quinoline-6-carboxylic acid derivatives were synthesized from 2-aminothiophenol by a five-step reaction, evaluated for in-vitro and in-vivo antimycobacterial activities against Mycobacterium tuberculosis H37Rv (MTB), multi-drug resistant Mycobacterium tuberculosis (MDR-TB), and Mycobacterium smegmatis (MC2), and also tested for the ability to inhibit the supercoiling activity of DNA gyrase from M. smegmatis. Among the thirty-four synthesized compounds, 2-(3-(diethylcarbamoyl)piperidin-1-yl)-)-3-fluoro-5,12-dihydro-5-oxobenzothiazolo[3,2-a]quinoline-6-carboxylic acid (7l) was found to be the most active compound in vitro with MIC of 0.18 and 0.08 microM against MTB and MTR-TB, respectively. Compound 7l was found to be 2 and 570 times more potent than isoniazid against MTB and MDR-TB, respectively. In the in-vivo animal model 7l decreased the bacterial load in lung and spleen tissues with 2.78 and 3.12-log10 protections, respectively, at the dose of 50 mg/kg body weight. 相似文献
153.
Glutamate racemase (MurI) catalyzes the interconversion of l-glutamate to d-glutamate, one of the essential amino acids present in the peptidoglycan. In addition to this essential enzymatic function, MurI from Escherichia coli, Bacillus subtilis and Mycobacterium tuberculosis inhibit DNA gyrase activity. A single gene for murI found in the Mycobacterium smegmatis genome was cloned and overexpressed in a homologous expression system to obtain a highly soluble enzyme. In addition to the racemization activity, M. smegmatis MurI inhibits DNA gyrase activity by preventing DNA binding of gyrase. The sequestration of the gyrase by MurI results in inhibition of all reactions catalyzed by DNA gyrase. More importantly, MurI overexpression in vivo in mycobacterial cells provides protection against the action of ciprofloxacin. The DNA gyrase-inhibitory property thus appears to be a typical characteristic of MurI and would have probably evolved to either modulate the function of the essential housekeeping enzyme or to provide protection to gyrase against gyrase inhibitors, which cause double-strand breaks in the genome. 相似文献
154.
We assign a function for a small protein, YacG encoded by Escherichia coli genome. The NMR structure of YacG shows the presence of an unusual zinc-finger motif. YacG was predicted to be a part of DNA gyrase interactome based on protein-protein interaction network. We demonstrate that YacG inhibits all the catalytic activities of DNA gyrase by preventing its DNA binding. Topoisomerase I and IV activities remain unaltered in the presence of YacG and its action appears to be restricted only to DNA gyrase. The inhibition of the enzyme activity is due to the binding of YacG to carboxyl terminal domain of GyrB. Overexpression of YacG results in growth inhibition and alteration in DNA topology due to uncontrolled inhibition of gyrase. 相似文献
155.
Bonam M Christopher D Cipolla D Donovan B Goodwin D Holmes S Lyapustina S Mitchell J Nichols S Pettersson G Quale C Rao N Singh D Tougas T Van Oort M Walther B Wyka B 《AAPS PharmSciTech》2008,9(2):404-413
The purpose of this article is to catalogue in a systematic way the available information about factors that may influence
the outcome and variability of cascade impactor (CI) measurements of pharmaceutical aerosols for inhalation, such as those
obtained from metered dose inhalers (MDIs), dry powder inhalers (DPIs) or products for nebulization; and to suggest ways to
minimize the influence of such factors. To accomplish this task, the authors constructed a cause-and-effect Ishikawa diagram
for a CI measurement and considered the influence of each root cause based on industry experience and thorough literature
review. The results illustrate the intricate network of underlying causes of CI variability, with the potential for several
multi-way statistical interactions. It was also found that significantly more quantitative information exists about impactor-related
causes than about operator-derived influences, the contribution of drug assay methodology and product-related causes, suggesting
a need for further research in those areas. The understanding and awareness of all these factors should aid in the development
of optimized CI methods and appropriate quality control measures for aerodynamic particle size distribution (APSD) of pharmaceutical
aerosols, in line with the current regulatory initiatives involving quality-by-design (QbD).
Editorial Comment: The International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS) is an international
association of innovator and generic companies that develop, manufacture or market orally inhaled and nasal drug products
for local and systemic treatment of a variety of debilitating diseases such as asthma, chronic obstructive pulmonary disease
and diabetes. IPAC-RS is committed to advancing consensus-based, scientifically driven standards and regulations for these
products, with the purpose of facilitating the availability of high-quality, safe, and efficacious drug products to patients. 相似文献
156.
157.
158.
Evgenia R. Gatiatulina Olga N. Nemereshina Joanna Suliburska Tejo Prakash Nagaraja Anastasia A. Skalnaya Alexandr A. Nikonorov Anatoly V. Skalny Alexey A. Tinkov 《Biological trace element research》2017,175(1):79-86
The interaction between iron and copper has been discussed in association with human health and diseases for many years. Ceruloplasmin, a multi-copper oxidase, is mainly involved in iron metabolism and its genetic defect, aceruloplasminemia (ACP), shows neurological disorders and diabetes associated with excessive iron accumulation, but little is known about the state of copper in the brain. Here, we investigated localization of these metals in the brains of three patients with ACP using electron microscopes equipped with an energy-dispersive x-ray analyzer. Histochemically, iron deposition was observed mainly in the basal ganglia and dentate nucleus, and to lesser degree in the cerebral cortex of the patients, whereas copper grains were not detected. X-ray microanalysis identified two types of iron-rich particles in their brains: dense bodies, namely hemosiderins, and their aggregated inclusions. A small number of hemosiderins and most inclusions contained a significant amount of copper which was enough for distinct Cu x-ray images. These copper-containing particles were observed more frequently in the putamen and dentate nucleus than the cerebral cortex. Coexistence of iron and copper was supported by good correlations in the molecular ratios between these two metals in iron-rich particles with Cu x-ray image. Iron-dependent copper accumulation in iron-rich particles may suggest that copper recycling is enhanced to meet the increased requirement of cuproproteins in iron overload brain. In conclusion, the iron-rich particles with Cu x-ray image were found in the ACP brain. 相似文献
159.
Mehta Rucha Harishbhai Ponnuchamy Manivel Kumar Jitendra Reddy Nagaraja Reddy Rama 《Functional & integrative genomics》2017,17(1):1-25
Functional & Integrative Genomics - De novo assembly of reads produced by next-generation sequencing (NGS) technologies offers a rapid approach to obtain expressed gene sequences for non-model... 相似文献
160.
Anuj Sharma Raghavendar Chandran Erin S. Barry Manish Bhomia Mary Anne Hutchison Nagaraja S. Balakathiresan Neil E. Grunberg Radha K. Maheshwari 《PloS one》2014,9(11)
Wars in Iraq and Afghanistan have highlighted the problems of diagnosis and treatment of mild traumatic brain injury (mTBI). MTBI is a heterogeneous injury that may lead to the development of neurological and behavioral disorders. In the absence of specific diagnostic markers, mTBI is often unnoticed or misdiagnosed. In this study, mice were induced with increasing levels of mTBI and microRNA (miRNA) changes in the serum were determined. MTBI was induced by varying weight and fall height of the impactor rod resulting in four different severity grades of the mTBI. Injuries were characterized as mild by assessing with the neurobehavioral severity scale-revised (NSS-R) at day 1 post injury. Open field locomotion and acoustic startle response showed behavioral and sensory motor deficits in 3 of the 4 injury groups at day 1 post injury. All of the animals recovered after day 1 with no significant neurobehavioral alteration by day 30 post injury. Serum microRNA (miRNA) profiles clearly differentiated injured from uninjured animals. Overall, the number of miRNAs that were significantly modulated in injured animals over the sham controls increased with the severity of the injury. Thirteen miRNAs were found to identify mTBI regardless of its severity within the mild spectrum of injury. Bioinformatics analyses revealed that the more severe brain injuries were associated with a greater number of miRNAs involved in brain related functions. The evaluation of serum miRNA may help to identify the severity of brain injury and the risk of developing adverse effects after TBI. 相似文献